Therefore, to assess this topic, we considered whether the combination of HRV and serum CEA can assist the clinical diagnosis of breast cancer at an early stage and improve its detection rate and the results represented that the diagnostic AUC of combining awake TP, awake LF, and serum CEA were 0.901 and the specificity was 0.944. This evidence concerns the gene CEACAM5 and breast carcinoma.